Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more
Baird Medical Investment Holdings Limited (BDMD) - Net Assets
Latest net assets as of September 2025: $35.62 Million USD
Based on the latest financial reports, Baird Medical Investment Holdings Limited (BDMD) has net assets worth $35.62 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($76.99 Million) and total liabilities ($41.37 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $35.62 Million |
| % of Total Assets | 46.27% |
| Annual Growth Rate | N/A |
| 5-Year Change | 487.85% |
| 10-Year Change | N/A |
| Growth Volatility | 45.76 |
Baird Medical Investment Holdings Limited - Net Assets Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual net assets of Baird Medical Investment Holdings Limited from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $39.76 Million | +11.35% |
| 2023-12-31 | $35.71 Million | +38.52% |
| 2022-12-31 | $25.78 Million | +62.50% |
| 2021-12-31 | $15.86 Million | +134.53% |
| 2020-12-31 | $6.76 Million | +129.96% |
| 2019-12-31 | $-22.58 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Baird Medical Investment Holdings Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4243595100.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $26.76 Million | 67.49% |
| Common Stock | $2.56K | 0.01% |
| Other Comprehensive Income | $1.45 Million | 3.66% |
| Other Components | $11.44 Million | 28.85% |
| Total Equity | $39.66 Million | 100.00% |
Baird Medical Investment Holdings Limited Competitors by Market Cap
The table below lists competitors of Baird Medical Investment Holdings Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
FAT Brands Inc
NASDAQ:FATBW
|
$16.14 Million |
|
Hotel Fitra International Tbk PT
JK:FITT
|
$16.15 Million |
|
Higgstec
TWO:5220
|
$16.16 Million |
|
IokCompany Co. Ltd
KQ:078860
|
$16.16 Million |
|
NSE S.A. EO 155
F:7YM
|
$16.12 Million |
|
Yuan Jen Enterprises Co Ltd
TW:1725
|
$16.12 Million |
|
Australian Vintage Ltd
PINK:AUVGF
|
$16.12 Million |
|
Scienture Holdings, Inc.
NASDAQ:SCNX
|
$16.12 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Baird Medical Investment Holdings Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 35,750,644 to 39,659,138, a change of 3,908,494 (10.9%).
- Net income of 12,453,369 contributed positively to equity growth.
- New share issuances of 2,900,000 increased equity.
- Other comprehensive income decreased equity by 1,053,154.
- Other factors decreased equity by 10,391,721.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $12.45 Million | +31.4% |
| Share Issuances | $2.90 Million | +7.31% |
| Other Comprehensive Income | $-1.05 Million | -2.66% |
| Other Changes | $-10.39 Million | -26.2% |
| Total Change | $- | 10.93% |
Book Value vs Market Value Analysis
This analysis compares Baird Medical Investment Holdings Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.35x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-3.05 | $2.09 | x |
| 2020-12-31 | $1.00 | $2.09 | x |
| 2021-12-31 | $0.72 | $2.09 | x |
| 2022-12-31 | $3.61 | $2.09 | x |
| 2023-12-31 | $4.71 | $2.09 | x |
| 2024-12-31 | $1.55 | $2.09 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Baird Medical Investment Holdings Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 31.40%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 33.62%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.97x
- Recent ROE (31.40%) is below the historical average (72.03%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -58.83% | 1.04x | 0.00x | $-4.99 Million |
| 2020 | 98.44% | 39.18% | 1.06x | 2.36x | $6.38 Million |
| 2021 | 224.40% | 42.12% | 1.06x | 5.02x | $11.16 Million |
| 2022 | 48.47% | 35.82% | 0.82x | 1.64x | $9.98 Million |
| 2023 | 29.50% | 33.52% | 0.55x | 1.59x | $6.97 Million |
| 2024 | 31.40% | 33.62% | 0.48x | 1.97x | $8.49 Million |
Industry Comparison
This section compares Baird Medical Investment Holdings Limited's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Baird Medical Investment Holdings Limited (BDMD) | $35.62 Million | 0.00% | 1.16x | $16.14 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |